Cas no 524-15-2 (γ-Fagarine)

γ-Fagarine is a bioactive alkaloid compound primarily derived from plants of the Rutaceae family, such as Zanthoxylum species. It exhibits notable pharmacological properties, including anti-inflammatory, analgesic, and potential anticancer effects. Structurally classified as a furoquinoline alkaloid, γ-Fagarine has been studied for its ability to modulate cellular signaling pathways, particularly those involving NF-κB and MAPK. Its high purity and stability make it suitable for research applications in drug discovery and mechanistic studies. The compound’s well-defined molecular structure (C15H13NO3) ensures reproducibility in experimental settings. γ-Fagarine is commonly utilized in biochemical assays and as a reference standard in phytochemical analysis.

γ-Fagarine structure

Product Name:γ-Fagarine

CAS No:524-15-2

MF:C₁₃H₁₁NO₃

MW:229.231343507767

CID:373727

Update Time:2025-11-06

γ-Fagarine Chemical and Physical Properties

Names and Identifiers

- Fagarine
- γ-Fagarine
- 4,8-Dimethoxyfuro[2,3-b]quinoline
- gamma-Fagarine
- 8-Methoxydictamine
- g-fagarine
- 8-Methoxydictamnine
- [ "4", "8-Dimethoxyfuro[2", "3-b]quinoline" ]
- 4
- .gamma.-Fagarine
- GKS8Q870TY
- Furo(2,3-b)quinoline, 4,8-dimethoxy-
- MLS000532362
- ST077119
- SMR000137321
- 4,8-Dimethoxy-Furo[2,3-b]quinoline
- 4,8-Dimethoxy-Furo(2,3-b)quinoline
- Furo[2,3-b]quinoline, 4,8-dimethoxy-
- gamma-fargarine
- 8-Methoxy-Dictamine
- Opera_ID_990
- Cambridge id 5255764
- Oprea1_404574
- Oprea1_872079
- CBDivE_012859
- MLS001048993
- Inchi： 1S/C13H11NO3/c1-15-10-5-3-4-8-11(10)14-13-9(6-7-17-13)12(8)16-2/h3-7H,1-2H3
- InChI Key： KFBCTNNQFGONHB-UHFFFAOYSA-N
- SMILES： O1C=CC2C1=NC1C(=CC=CC=1C=2OC)OC
- BRN： 0212820

Computed Properties

Exact Mass: 229.07400
Monoisotopic Mass: 229.074
Isotope Atom Count: 0
Hydrogen Bond Donor Count: 0
Hydrogen Bond Acceptor Count: 4
Heavy Atom Count: 17
Rotatable Bond Count: 2
Complexity: 273
Covalently-Bonded Unit Count: 1
Defined Atom Stereocenter Count: 0
Undefined Atom Stereocenter Count : 0
Defined Bond Stereocenter Count: 0
Undefined Bond Stereocenter Count: 0
Topological Polar Surface Area: 44.5
Molecular Weight: 229.23
XLogP3: 2.9

Experimental Properties

Color/Form: Powder
Density: 1.2084 (rough estimate)
Melting Point: 142°
Boiling Point: 371.13°C (rough estimate)
Flash Point: 184.2°C
Refractive Index: 1.5500 (estimate)
Solubility: 8.779 mg/L @ 25 °C (est)
PSA: 44.49000
LogP: 2.99820

γ-Fagarine Customs Data

HS CODE：2934999090
Customs Data：

China Customs Code:
2934999090

Overview:

2934999090. Other heterocyclic compounds. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%

Declaration elements:

Product Name, component content, use to

Summary:

2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

γ-Fagarine Pricemore >>

Related Categories	No.	Product Name	Cas No.	Purity	Specification	Price	update time
TRC	F524250-0.5mg	Fagarine	524-15-2		0.5mg	$ 275.00	2023-02-03
TRC	F524250-1mg	Fagarine	524-15-2		1mg	$534.00	2023-05-18
Chengdu Biopurify Phytochemicals Ltd	SBP00591-10mg	γ-Fagarine	524-15-2	98%	10mg	$290	2023-09-20
Chengdu Biopurify Phytochemicals Ltd	SBP00591-20mg	γ-Fagarine	524-15-2	98%	20mg	$490	2023-09-20
Chengdu Biopurify Phytochemicals Ltd	SBP00591-5mg	γ-Fagarine	524-15-2	98%	5mg	$160	2023-09-20
SHANG HAI TAO SHU Biotechnology Co., Ltd.	TN1138-1 mg	gamma-Fagarine	524-15-2		1mg	￥1953.00	2022-04-26
ChemScence	CS-0024453-1mg	γ-Fagarine	524-15-2		1mg	$200.0	2022-04-27
ChemScence	CS-0024453-5mg	γ-Fagarine	524-15-2		5mg	$500.0	2022-04-27
SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd.	F13760-5mg	4,8-Dimethoxyfuro[2,3-b]quinoline	524-15-2	,HPLC≥98%	5mg	￥3200.0	2023-09-07
MedChemExpress	HY-N3918-1mg	γ-Fagarine	524-15-2		1mg	￥2000	2021-07-09

γ-Fagarine Suppliers

Amadis Chemical Company Limited

Gold Member

Audited Supplier

(CAS:524-15-2)γ-Fagarine

Order Number:A1203742

Stock Status:in Stock

Quantity:5mg

Purity:99%

Pricing Information Last Updated:Friday, 30 August 2024 02:51

Price ($):562.0

Email:[email protected]

Product Official Link

γ-Fagarine Related Literature

1. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?

Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837
2. Fe/Fe3C@C nanoparticles encapsulated in N-doped graphene–CNTs framework as an efficient bifunctional oxygen electrocatalyst for robust rechargeable Zn–air batteries?

Zhiyan Chen,Nan Wu,Yaobing Wang,Bing Wang,Yingde Wang J. Mater. Chem. A, 2018,6, 516-526
3. Enabling chloride salts for thermal energy storage: implications of salt purity?

J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
4. Dissolved oxygen sensor based on fluorescence quenching of oxygen-sensitive ruthenium complexes immobilized in sol–gel-derived porous silica coatings

Analyst, 1996,121, 785-788
5. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?

Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305

Related Categories

Additional information on γ-Fagarine

Market Research and Analysis of γ-Fagarine in Chemical-Biomedical Fields

γ-Fagarine, a natural product with the CAS number 524-15-2, has garnered significant attention in the chemical-biomedical industry due to its unique properties and potential applications. This compound, primarily derived from specific plant sources, exhibits notable anti-inflammatory and antioxidant activities, making it a promising candidate for drug development and therapeutic interventions.

The global market for natural products like γ-Fagarine is experiencing steady growth, driven by increasing demand for bioactive compounds in pharmaceuticals, nutraceuticals, and cosmetics. Recent studies have highlighted its potential in treating chronic inflammatory diseases and oxidative stress-related disorders, further fueling its market prospects.

To understand the current landscape, this analysis delves into the latest research findings, market demands, and supply chain dynamics surrounding γ-Fagarine. By integrating data from academic journals, industry reports, and supplier networks, this report aims to provide a comprehensive overview of the opportunities and challenges associated with this compound.

The methodology involves a thorough review of scientific literature to identify key research trends and advancements in γ-Fagarine's pharmacology. Additionally, market data analysis is conducted to assess current production capacities, pricing trends, and regional demand patterns. This dual approach ensures a holistic understanding of both the scientific and commercial aspects of γ-Fagarine.

Results indicate that γ-Fagarine's demand is concentrated in regions with advanced healthcare systems and a growing emphasis on natural medicine. Key players in the supply chain are actively exploring sustainable extraction methods to meet rising global demand while maintaining quality standards.

In conclusion, γ-Fagarine presents a lucrative opportunity for stakeholders in the chemical-biomedical sector. Its versatile applications and growing scientific validation position it as a valuable asset in both research and commercial markets. This report underscores the importance of continued investment in R&D to unlock its full potential while addressing challenges such as scalability and regulatory compliance.

524-15-2 (γ-Fagarine) Related Products

Recommended suppliers